Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

7.30p
   
  • Change Today:
    -0.40p
  • 52 Week High: 9.00p
  • 52 Week Low: 2.25p
  • Currency: UK Pounds
  • Shares Issued: 1,061.80m
  • Volume: 2,503,075
  • Market Cap: £77.51m

Latest ShareCast News

Shield Therapeutics reports strongest quarterly performance to date

By Josh White

Date: Thursday 23 Oct 2025

(Sharecast News) - Shield Therapeutics reported its strongest quarterly performance to date on Thursday, with third-quarter Accrufer prescriptions rising about 15% from the previous quarter and revenues reaching a new high, keeping the company on track to become cash flow positive by year-end.

Shield Therapeutics gets FDA priority review to extend Accrufer indication

By Josh White

Date: Thursday 04 Sep 2025

(Sharecast News) - Shield Therapeutics said on Thursday that the US Food and Drug Administration (FDA) has granted priority review to extend the indication of its oral iron therapy Accrufer/Feraccru to adolescents aged 10 and above, with potential approval expected in 2026.

Shield Therapeutics reports sharp rise in first-half revenue

By Josh White

Date: Wednesday 03 Sep 2025

(Sharecast News) - Shield Therapeutics reported a sharp rise in first-half revenue on Wednesday, as sales of its oral iron therapy Accrufer accelerated across key markets, leaving the company on track to reach cash flow breakeven by the end of 2025.

Shield Therapeutics inks exclusive licence agree... 22-Apr-2025 ShareCast
Shield Therapeutics appoints Anders Lundstrom as... 27-Jan-2025 ShareCast
Shield Therapeutics secures $10m investment, ann... 06-Dec-2024 ShareCast
Shield Therapeutics reports strong quarter for A... 29-Oct-2024 ShareCast
Shield Therapeutics announces promising paediatr... 25-Sep-2024 ShareCast
Shield Therapeutics iron deficiency treatment ap... 27-Aug-2024 ShareCast
Shield Therapeutics net sales grow in Q2, CEO st... 24-Jul-2024 ShareCast
Shield Therapeutics reports strong US progress 07-Dec-2023 ShareCast
Shield's Canadian partner files new drug submiss... 21-Mar-2022 ShareCast
Shield Therapeutics revenue falls in line with e... 17-Feb-2022 ShareCast
Shield Therapeutics enters Accrufer licensing de... 05-Jan-2022 ShareCast
Shield shares surge on expansion of US coverage ... 16-Dec-2021 ShareCast
Shield Therapeutics appoints chief medical officer 27-Sep-2021 ShareCast
Shield Therapeutics swings to losses in first half 17-Aug-2021 ShareCast
Shield Therapeutics inks exclusive licence for '... 12-Aug-2021 ShareCast
Shield Therapeutics appoints industry veteran Gr... 28-May-2021 ShareCast
Shield taps Hans-Peter Rudolf as its new finance... 22-Mar-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 7.30p
Change Today -0.40p
% Change -5.19 %
52 Week High 9.00p
52 Week Low 2.25p
Volume 2,503,075
Shares Issued 1,061.80m
Market Cap £77.51m

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average
70.73% above the sector average70.73% above the sector average70.73% above the sector average70.73% above the sector average70.73% above the sector average
Price Trend
58.74% above the market average58.74% above the market average58.74% above the market average58.74% above the market average58.74% above the market average
77.27% above the sector average77.27% above the sector average77.27% above the sector average77.27% above the sector average77.27% above the sector average
Income Not Available
Growth
64.03% above the market average64.03% above the market average64.03% above the market average64.03% above the market average64.03% above the market average
79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 24-Oct-2025

Time Volume / Share Price
16:26 83,607 @ 7.30p
15:37 30,000 @ 7.30p
15:06 4,220 @ 7.37p
14:33 48,239 @ 7.20p
14:07 10,000 @ 7.20p

STX Key Personnel

CEO Anders Lundstrom

Top of Page